Cargando…
Theranostic nanoparticles for the management of thrombosis
Acute thrombosis and thromboembolisms are one of the leading causes of mortality and morbidity in both developed and developing countries, placing a huge burden on health and economic systems. Early diagnosis is critical but currently limited in accuracy and hampered by a narrow time frame, where th...
Autores principales: | Russell, Peije, Hagemeyer, Christoph Eugen, Esser, Lars, Voelcker, Nicolas Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965493/ https://www.ncbi.nlm.nih.gov/pubmed/35401833 http://dx.doi.org/10.7150/thno.70001 |
Ejemplares similares
-
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
por: Zhang, Weisen, et al.
Publicado: (2021) -
Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis
por: Wang, Xiaowei, et al.
Publicado: (2016) -
Magnetic Nanoparticles in Cancer Theranostics
por: Gobbo, Oliviero L., et al.
Publicado: (2015) -
Nanoparticle theranostics in cardiovascular inflammation
por: MacRitchie, Neil, et al.
Publicado: (2021) -
Hydroxyapatite Nanoparticles for Improved Cancer Theranostics
por: Kargozar, Saeid, et al.
Publicado: (2022)